Compare moats
Up to three covered companies, band by band. Every call is a curated editorial judgment, never a disclosed figure — and every band carries its cited basis.
| MaxLinear | RELX plc | |
|---|---|---|
| Moat rating | none MaxLinear’s FY2025 10-K does not show a durable advantage. Its income statement reports revenue of $693,263 thousand in 2023, $360,528 thousand in 2024 and $467,641 thousand in 2025, with operating losses of $38,221 thousand, $223,352 thousand and $126,890 thousand. The risk factors say “Increased competition has resulted in price pressure, decreased demand, reduced revenue and profitability, and loss of market share”; the business section says competitors include “companies with much longer operating histories, greater name recognition, and substantially greater financial, technical and operational resources”; and because its products “often are building block semiconductors” it also faces integrated-circuit makers, “some of which may be existing customers or platform partners”. Two customers were 28% of 2025 net revenue and the ten largest 65%, and “substantially all of our sales to date have been made on a purchase order basis”. Gross profit held up - $385,663 thousand, $194,782 thousand and $265,814 thousand for 2023 to 2025 - and the AI optical ramp has lifted 2026 results, but a revenue base that nearly halved in one year and three straight years of operating losses do not evidence a moat. | wide Independent sources support entrenched positions in RELX's two content businesses. In legal research, a Stanford-led study of legal AI tools (arXiv 2405.20362v1, 2024-05-30, https://arxiv.org/html/2405.20362v1) says Thomson Reuters and LexisNexis "have historically enjoyed a virtual duopoly over the legal research market" (citing a 2006 article for that point) and "continue to be two of the largest incumbents now selling legal AI products". In scientific publishing, Larivière, Haustein and Mongeon in PLOS ONE (2015-06-10, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0127502) found Reed-Elsevier published 24.1% of natural and medical sciences papers in 2013, the largest share, and that its Scientific, Technical & Medical division's profit margin "steadily increased from 30.6% to 38.9% between 2006 and 2013." RELX's 2025 Annual Report (published 2026-02-19) shows the economics continuing: revenue of £9,590m, adjusted operating profit of £3,342m and an adjusted operating margin of 34.8% against 33.9% in 2024, with 54% of revenue from subscriptions. The limits are in the same report. Its principal risks say "We operate in highly competitive and dynamic markets" that change with "technological innovations, such as the use of artificial intelligence" and "the entrance of new competitors". Exhibitions holds "a global market share of less than 10%" in "a fragmented industry", and the Chair noted "share price volatility across a number of sectors, including software and data services." Long-held positions in legal research and scientific publishing, with margins that have kept rising, support a wide rating. The main threat is AI-native competition, which has not yet slowed reported growth. |
| Moat type | none No single source of advantage in the 10-K is strong enough to name. MaxLinear has “over one thousand issued patents” and says consideration under intellectual property sale agreements “has previously been and is currently expected in the future be material”, but the same filing describes its products as building blocks that larger vendors can integrate, says some optical-interconnect customers are “module makers who are vertically integrated, where we compete with internally supplied components”, and claims only that “We believe that we compete favorably” on factors from product performance to price. Its RF-CMOS integration know-how is real, but nothing in the filing shows customers locked in or rivals unable to match it. | intangibles ip RELX says its advantage is proprietary content and data. The 2025 Annual Report says it builds products by combining "our unique content and comprehensive data sets with advanced technologies", describes Lexis+ AI as "built and trained on one of the world's largest repositories of accurate and exclusive legal content", and cites more than 3,000 Elsevier journals including the Cell Press and The Lancet families. On the H1 2026 results call (2026-07-23, https://www.relx.com/~/media/Files/R/RELX-Group/documents/investors/transcripts/first-half-results-2026-transcript.pdf) the CEO said Risk grows by "leveraging our unique contributory and proprietary datasets, with over 90% of revenue coming from machine-to-machine interactions." Independent support comes from PLOS ONE (2015), which says libraries face a publisher oligopoly in which "each product represents a unique value and cannot be replaced". According to the annual report, in June 2025 LexisNexis agreed a strategic alliance with Harvey, an AI platform for legal and professional services, under which LexisNexis "will integrate its Lexis+ AI capabilities (powered by LexisNexis content) within the Harvey platform". Switching costs add to this: legal products are sold "on a paid subscription basis, with subscriptions often under multi-year contracts." |
| Leadership | fast follower In its fastest-growing line MaxLinear is a second source. Deep Fundamental’s September 27, 2024 deep dive (https://deepfundamental.substack.com/p/deep-dive-optical-module-market) says “Marvell ($MRVL) and Broadcom ($AVGO) are two major suppliers of DSPs, with Marvell holding the top position in the market”, that “Coherent also sources heavily from Marvell, with Broadcom/ Maxlinear potentially serving as second supplier with 20-30% share”, and that MaxLinear offers “DSPs at about half the price of Marvell's if it can achieve a meaningful mass production volume of at least 100K units per month”. Keystone has since reached volume - management said on the Q2 2026 call that it “continues to ramp into high volume production at major hyperscale customers across U.S. and Asia” - but the 10-K names Broadcom, Qualcomm, Realtek, Skyworks, Credo, MediaTek, Marvell, MACOM, Texas Instruments, Analog Devices, Renesas, Microchip and Semtech as primary merchant competitors, and no third-party source found ranks MaxLinear first in any of its markets. | co leader RELX's own 2025 Annual Report ranks its businesses as Risk "Key verticals #1", STM "Global #1", Legal "US #2" and "Outside US #1 or #2", and Exhibitions "Global #2". Independent sources, both dated, support two of these. PLOS ONE (2015) puts Reed-Elsevier first in natural and medical sciences publishing with 24.1% of 2013 papers, ahead of Springer (11.9%) and Wiley-Blackwell (11.3%). The Stanford study (2024-05-30) describes legal research as a historical duopoly of Thomson Reuters and LexisNexis, and found that "Lexis+ AI is the highest-performing system we test, answering 65% of our queries accurately." The publishing data is from 2013, Legal is second in the U.S. by RELX's own account, and the Risk and Exhibitions ranks are the company's own claims. That supports co-leader, not clear leader. |
| Pricing power | moderate Mixed. Gross profit has stayed in proportion through the cycle - the 10-K’s income statement shows $265,814 thousand on revenue of $467,641 thousand in 2025 - and the Q2 2026 release (https://www.sec.gov/Archives/edgar/data/0001288469/000128846926000050/a06302026exhibit991.htm) reports GAAP gross margin of 57.8% against 56.5% a year earlier, guiding Q3 to 57.0%-60.0%. But the 10-K says “From time to time, we have reduced the average unit price of our products due to competitive pricing pressures, new product introductions by us or our competitors, and for other reasons, and we expect that we will have to do so again in the future”, that under some distributor agreements “we provide protection for reductions in selling prices of the distributors' inventory”, and in optical DSPs it entered as the lower-priced challenger. | moderate The 2025 Annual Report says RELX products "often account for less than 1% of our customers' total cost base but can have a significant and positive impact on the economics of the remaining 99%", and reports a group adjusted operating margin of 34.8% in 2025 against 33.9% in 2024. On the H1 2026 call the CFO reported a margin of 35.5%. He attributed the gains to cost discipline: "we focus on ensuring that cost growth remains below revenue growth in all of our businesses." The CEO said that "roughly 3/4 of the renewal value is coming from the Lexis+ with Protégé package", which means renewals are moving customers onto the higher-value AI platform. Independent evidence on Elsevier is older. PLOS ONE (2015) says libraries "have to manage with less as prices increase" and that, because of the oligopoly, they are "more or less helpless". It also found the STM division's profit margin never fell below 30% over the 1991-2013 period it studied. RELX does not disclose list-price increases. Most of the evidence is margin-based. The margins are high and rising, but management credits the gains to keeping cost growth below revenue growth, and the only independent evidence of price increases is from 2015. That supports moderate, not strong, pricing power. |
| Summary | MaxLinear is a fabless designer of RF, analog and mixed-signal communications SoCs whose core skill, per its FY2025 10-K, is combining broadband RF and analog front ends with digital signal processing in standard CMOS. It sells into broadband access (cable, fiber PON and DSL gateways - approximately 44% of 2025 net revenue), home connectivity (Wi-Fi, MoCA, G.hn and Ethernet), wired and wireless infrastructure including optical data-center DSPs, and industrial and multi-market interface and power products. After a downturn that took revenue from $693,263 thousand in 2023 to $360,528 thousand in 2024, the AI optical ramp is turning it around: the Q2 2026 release reports revenue of $168,847 thousand, up 55% year over year, with the infrastructure business up 145% on the Keystone PAM4 DSP ramp for 800G, and management raised its 2026 optical data-center revenue outlook to $210 million-$230 million on the call. The moat question is whether that growth rests on anything durable. In optical DSPs MaxLinear entered as a lower-priced second source to Marvell; elsewhere it competes with Broadcom, Qualcomm, Realtek and MediaTek, which can integrate the functions it sells; customers are concentrated; and the 10-K still carries the Silicon Motion arbitration over its terminated merger, whose outcome it says it cannot predict. On this record MaxLinear is a technically capable challenger without a moat. | RELX sells information-based analytics and decision tools in four business areas. In 2025, per its Annual Report, Risk (LexisNexis Risk Solutions) had revenue of £3,485m and adjusted operating profit of £1,305m; Scientific, Technical & Medical (Elsevier) £2,714m and £1,035m; Legal (LexisNexis Legal & Professional) £1,806m and £415m; and Exhibitions (RX) £1,186m and £410m. The moat rests on content and data that are hard to replicate. A Stanford study describes a historical Westlaw-LexisNexis "virtual duopoly" in legal research. A PLOS ONE study found Reed-Elsevier the largest publisher of natural and medical sciences papers in 2013, and RELX reports that Elsevier articles accounted for "over 18% of global research output and 29% of citations" in its latest comparison. Risk is built on contributory databases such as the C.L.U.E. claims history database, which "collects and reports up to seven years of US personal automobile, property claims and small business information". The products are cheap relative to what customers spend: RELX says they "often account for less than 1% of our customers' total cost base". Group adjusted operating margin rose to 34.8% in 2025 and to 35.5% in the first half of 2026. AI is the main test of the moat. RELX is turning it into upsell: about 90% of Legal new-sales value now comes from the AI-enabled Lexis+ with Protégé platform, and Legal underlying revenue growth reached 10% in H1 2026. On the same call, an analyst cited AI-native legal players Harvey and Legora with combined annual recurring revenue above $400 million, and the CEO said RELX is "not going to be the leader" in the much larger legal workflow software market. RELX names the shift to open access as a principal risk for Elsevier. On the 2026 call, an analyst raised a U.S. OMB proposal to make journal subscription costs and article processing charges unallowable expenses on federal research awards. |
| Chain position | MaxLinear sells chips, much of it through Asian distributors, ODMs and module makers - products shipped to Asia were 82% of 2025 net revenue, including 49% to Hong Kong - that build cable modems, PON terminals, Wi-Fi gateways, base-station radios and optical transceivers for operators and hyperscale data centers. In the AI chain it sits beside the optical-module makers as a DSP supplier, competing with Marvell and Broadcom and, at vertically integrated module makers, with internally supplied components. | An AI-application-layer user of frontier models: on the H1 2026 call the CEO said RELX takes AI tools "from the sort of frontier lab companies" and runs them inside its own products on verified content. The 2025 Annual Report says LexisNexis will integrate Lexis+ AI capabilities, powered by LexisNexis content, within the Harvey platform. |
| Products (share / barrier) |
|
|
| Long-horizon vote | +0.01 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.30 at weight 0.20 · swarm neutral Editorial prior, not backtested. |